In Missouri, DuPont Nutrition & Health and Inbiose partnered to jointly develop selected fucosylated human milk oligosaccharides for infant nutrition. HMOs are a group of unique oligosaccharides found in mother’s milk that have been identified as important in shaping an infant’s gut microbiome and for a balanced immune system. A growing body of evidence suggests that HMOs benefit an infant’s health by supporting digestive, immune and cognitive development.
“HMOs are found naturally in mother’s milk and represent the next generation of functional oligosaccharides. The inclusion of HMOs will be a significant advancement in the improvement of infant formula,” said Martin Kullen, DuPont’s global R&D leader for Probiotics, Cultures, Food Protection and HMOs.
The partnership combines Inbiose’s specialty carbohydrates production platform with DuPont’s industrial-scale fermentation, regulatory and health science expertise, and global market access. The team is developing the ingredients for a 2017 market introduction by implementing an industrial-scale fermentation process and submission for regulatory approvals.